Atea Pharmaceuticals, Inc. (AVIR)
4.16
+0.02
(+0.48%)
USD |
NASDAQ |
Feb 10, 16:00
4.05
-0.11
(-2.64%)
Pre-Market: 20:00
Atea Pharmaceuticals EPS Diluted (Quarterly) : -0.5319 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Aclaris Therapeutics, Inc. | -0.1192 |
| PMV Pharmaceuticals, Inc. | -0.3974 |
| Instil Bio, Inc. | -2.011 |
| Erasca, Inc. | -0.1079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.05M |
| Total Expenses (Quarterly) | 42.05M |
| Enterprise Value | -3.256M |
| Earnings Yield | -42.67% |
| Normalized Earnings Yield | -42.67 |